Skip to main content

Table 1 Blood glucose monitoring test strips claimed and costs by treatment category, NSSPP for 2005/06

From: The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors' Pharmacare Program in Nova Scotia, Canada

Treatment Category

N (%) Number of Beneficiaries

Mean (SD) SMBG Test Strips Claimed*

Mean (SD) Government Contribution Through the NSSPP+ (Can $)

Mean (SD) Beneficiary Contribution Through Copayment and MAC policy+ (Can $)

Mean (SD) Total Cost+ (Can$)

Insulin products only

1786 (13.2)

2.0 (1.5)

562.17 (414.52)

52.34 (43.58)

614.50 (441.31)

Oral antihyperglycemic agents only

7252 (53.5)

1.0 (0.9)

271.61 (241.59)

39.90 (38.18)

311.51 (262.97)

Insulin products + Oral antihyperglycemic agents

1006 (7.4)

2.0 (1.3)

546.94 (361.59)

46.26 (38.90)

593.20 (382.50)

No reimbursed diabetes medications

3520 (25.9)

0.7 (0.6)

182.13 (177.88)

36.75 (34.84)

218.89 (197.77)

  1. *Results per day
  2. +Annual costs per beneficiary